| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 04/15/2004 | US20040072816 Dysmenorrhea; congestive heart failure; liver disorders; vision defects |
| 04/15/2004 | US20040072808 Menopause; hormone replacement therapy; controlling dosage |
| 04/15/2004 | US20040072297 Comprises maternal protein (MATER) for treatment of infertility and reduced fertility; contraceptives |
| 04/15/2004 | US20040071711 Imaging, diagnosis and treatment of disease |
| 04/15/2004 | US20040071701 Nerve growth factor antagonist for treating pain caused by physiological disorder, no side effects |
| 04/15/2004 | US20040071679 Topical application of Lactobacillus strain; colorimetric analysis |
| 04/15/2004 | CA2503674A1 Quinazolin-4-one derivatives |
| 04/15/2004 | CA2500869A1 Spiro compounds, medicinal compositions containing the same and intermediates of the compounds |
| 04/14/2004 | EP1406908A1 Morpholine-bridged pyrazolopyridine derivatives |
| 04/14/2004 | EP1406900A1 Novel compounds, their preparation and use |
| 04/14/2004 | EP1406897A2 Compounds |
| 04/14/2004 | EP1406883A1 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3(gsk3) |
| 04/14/2004 | EP1406877A1 Heterocyclic amines for the treatment of conditions associated with gsk-3 |
| 04/14/2004 | EP1406872A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/14/2004 | EP1406867A2 Thiolalkyl benzoic acid derivatives |
| 04/14/2004 | EP1406858A1 Substituted 4-aminocyclohexanols |
| 04/14/2004 | EP1406644A2 Modified proteins, designer toxins, and methods of making thereof |
| 04/14/2004 | EP1406641A2 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |
| 04/14/2004 | EP1406634A1 Combination of drospirenone and an estrogen sulphamate for hrt |
| 04/14/2004 | EP1406628A1 Tetrahydroquinoline derivatives |
| 04/14/2004 | EP1406622A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/14/2004 | EP1406611A2 Method for treating fibrotic diseases or other indications |
| 04/14/2004 | EP1406609A2 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 04/14/2004 | EP1406591A1 Pharmaceutical composition for nasal delivery of estradiol and norethisterone |
| 04/14/2004 | EP1406496A1 Method and composition for enhancing sexual desire |
| 04/14/2004 | EP1202994B1 New compounds |
| 04/14/2004 | EP1200419B1 Aminothiazole derivatives and their use as crf receptor ligands |
| 04/14/2004 | EP1189583A4 Indole derivatives |
| 04/14/2004 | EP0927040B1 Process to obtain oestrogens from mare's urine |
| 04/14/2004 | EP0925298B1 Substituted 6,6-hetero-bicyclic derivatives |
| 04/14/2004 | EP0792152B1 Methods of contraception |
| 04/14/2004 | CN1489579A 7-heterocyclyl quinoline and thieno[2,3,-b] pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 04/14/2004 | CN1489475A preventives or remedies for endometeriosis |
| 04/14/2004 | CN1489467A Pharmacentical formulation comprising pyrazolo[4,3-d] pyrimdine and endothelin receptor antagonists or thienopyrimidines and endothelin receptor antagonists |
| 04/14/2004 | CN1488400A Preparation for preventing and curing endometritis for dairy cattle and preparing method thereof |
| 04/14/2004 | CN1488396A Chinese medicine for treating asynodia |
| 04/14/2004 | CN1488385A Chinese medicine composition for treating climacteric metancholia for women and preparing method thereof |
| 04/14/2004 | CN1488369A Chinese medicine powder for treating gynaopathy |
| 04/14/2004 | CN1488362A Chinese medicine preparation capable of promoting, milk secretion for delivery woman |
| 04/14/2004 | CN1488347A Use of raloxifene for preparing medicine for treating, fibroid and endometriosis |
| 04/14/2004 | CN1145627C Pyrazolo [4,3-d] pyrimidines |
| 04/14/2004 | CN1145618C Cycloformate derivatives as progesterone receptor modulators |
| 04/14/2004 | CN1145616C Novel amino-triazole compound, its preparation method and drug composition containing them |
| 04/14/2004 | CN1145614C Irreversible inhibitors of tyrosine kinases, its pharmaceutical use and medicine composition thereof |
| 04/14/2004 | CN1145610C Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
| 04/14/2004 | CN1145496C Novel formulation for peptide release |
| 04/14/2004 | CN1145495C Orally applied medicine for treating diseases caused by Yang deficciency and its producing method |
| 04/14/2004 | CN1145480C Contraceptive for male |
| 04/13/2004 | US6720427 Used to treat abnormal cell growth and central nervous system disorders |
| 04/13/2004 | US6720336 4,4-biarylpiperidine derivatives |
| 04/10/2004 | CA2445212A1 Treatment of sexual dysfunction |
| 04/08/2004 | WO2004029192A2 Producing method of tien hsien liquid |
| 04/08/2004 | WO2004028553A1 A method of modulating cellular development |
| 04/08/2004 | WO2004028543A1 Progesterone receptor antagonists for reducing incidence of stillborn pigs |
| 04/08/2004 | WO2004007522A3 Hormone-based nitrogen monoxide donor compounds and use thereof in obstetrics and gynecology |
| 04/08/2004 | WO2004004634A3 Infertility treatment with exemestane |
| 04/08/2004 | WO2004000205A3 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 04/08/2004 | WO2003106452A3 Antagonists of melanin concentrating hormone receptor |
| 04/08/2004 | WO2003092605A9 Protease inhibitors |
| 04/08/2004 | WO2003086314A3 Tyrosine kinase inhibitors |
| 04/08/2004 | WO2003084521A3 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |
| 04/08/2004 | WO2003068732A3 Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds |
| 04/08/2004 | WO2003066077A3 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 04/08/2004 | WO2003063893A3 Fgfr agonists |
| 04/08/2004 | US20040068014 Medicinal compositions comprising diclofenac and ornoprostil |
| 04/08/2004 | US20040068005 Pharmaceutical combinations |
| 04/08/2004 | US20040067979 N-bridged selective androgen receptor modulators and methods of use thereof |
| 04/08/2004 | US20040067957 Methods of treating or preventing restless leg syndrome using sibutramine metabolites |
| 04/08/2004 | US20040067946 Phthalatyinone-piperidino-derivatives as pde4 inhibitors |
| 04/08/2004 | US20040067945 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 04/08/2004 | US20040067937 Guanylate cyclase stimulant; cardiovascular disorders; thrombosis; antiischemic agents; sexual disorders; antiinflammatory agents; central nervous system disorders |
| 04/08/2004 | US20040067932 Synergistic mixture; anticancer agents; therapy for skin cancer |
| 04/08/2004 | US20040067922 Pharmaceutical composition for treatment of phimosis using topical corticosteroid |
| 04/08/2004 | US20040067899 Administering glycyrrhizin, or salt thereof |
| 04/08/2004 | US20040067518 Isolated nucleic acid comprising a polynucleotide of given sequence; polypeptides; recombinant host cells; useful in diagnosing and treating disorders |
| 04/07/2004 | EP1405083A2 Natural ligand of gpcr chemr23 and uses thereof |
| 04/07/2004 | EP1404876A2 Interferon alpha-14 polymorphism |
| 04/07/2004 | EP1404806A1 Male contraceptives |
| 04/07/2004 | EP1404714A2 Nuclear hormone receptor ligand binding domain |
| 04/07/2004 | EP1404679A2 (hetero)aryl substituted benzofurans as 5-ht ligands |
| 04/07/2004 | EP1404672A1 Tyrosine kinase inhibitors |
| 04/07/2004 | EP1404667A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/07/2004 | EP1404665A1 Antimicrobial and radioprotective compounds |
| 04/07/2004 | EP1404371A2 Peptide-based compounds for targeting intergin receptors |
| 04/07/2004 | EP1404357A1 Gonadotropin releasing hormone antagonists in gel-forming concentrations |
| 04/07/2004 | EP1404350A2 Proteins associated with cell growth, differentiation, and death |
| 04/07/2004 | EP1404349A1 Fat-binding polymers |
| 04/07/2004 | EP1404344A2 Bone anabolic compounds and methods of use |
| 04/07/2004 | EP1404343A2 Therapeutic combinations for the treatment of hormone deficiencies |
| 04/07/2004 | EP1404339A2 Method for treating fibrotic diseases or other indications vi |
| 04/07/2004 | EP1404336A1 Compositions comprising cgmppde5 inhibitor for transdermal delivery to the erectile tissue of the penis |
| 04/07/2004 | EP1404325A2 Method for treating nerve injury caused by surgery |
| 04/07/2004 | EP1185272B1 Novel use of 1-[4-(5-cyanoindol-3yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine and its physiological acceptable salts for the treatment of bipolar disorders and mania |
| 04/07/2004 | EP1052997B1 Compositions comprising d-chiro-inositol for treating metabolic diseases characterized by hyperandrogenism and/or anovulation |
| 04/07/2004 | CN1487950A Androgenic 7-substituted 11-halogen steroids |
| 04/07/2004 | CN1487939A Amido ether substituted imidazoquinolines |
| 04/07/2004 | CN1487934A 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 04/07/2004 | CN1487933A Pyrazole compounds useful as protein kinase inhibitors |
| 04/07/2004 | CN1487931A Naphthostyrils compounds |
| 04/07/2004 | CN1487927A Diaminothiazoles |